Article Information
History
- April 7, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 7, 2022 - 00:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Laura C Saunders1,
- Guilhem J Collier1,
- Ho-Fung Chan1,
- Paul J C Hughes1,
- Laurie J Smith1,
- James Watson2,
- James Meiring2,
- Zoë Gabriel2,
- Thomas Newman2,
- Megan Plowright2,
- James A Eaden1,
- Jody Bray1,
- Helen Marshall1,
- David J Capener1,
- Leanne Armstrong1,
- Jennifer Rodgers1,
- Martin Brook1,
- Alberto M Biancardi1,
- Madhwesha R Rao1,
- Graham Norquay1,
- Oliver Rodgers1,
- Ryan Munro1,
- Neil J Stewart1,
- Allan Lawrie1,
- Gisli Jenkins3,
- James Grist4,
- Fergus Gleeson4,
- Frederick Wilson5,*,
- Anthony Cahn5,
- Andrew J Swift1,
- Smitha Rajaram2,
- Gary H Mills1,
- Lisa Watson2,
- Paul J Collini1,
- Rod Lawson2,
- A A Roger Thompson1 and
- Jim M Wild1,†
- 1Department of Infection, Immunity; Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
- 2Sheffield Teaching Hospitals, NHS Foundation TRUST, Sheffield, United Kingdom
- 3National Heart and Lung Institute, Imperial College London
- 4Department of Radiology, Oxford NHS Foundation Trust, Oxford, United Kingdom
- 5GlaxoSmithKline, Stevenage, United Kingdom
- ↵†Corresponding author: Jim Wild, Email address: j.m.wild{at}sheffield.ac.uk, Phone: +44 114 215 9141
Posted April 07, 2022.
Longitudinal lung function assessment of patients hospitalised with COVID-19 using 1H and 129Xe lung MRI
